Stryker Pre-Tax Profit Margin 2010-2024 | SYK
Current and historical pre-tax profit margin for Stryker (SYK) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Stryker pre-tax profit margin for the three months ending December 31, 2024 was .
| Stryker Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-12-31 | $22.60B | $3.49B | 15.45% |
| 2024-09-30 | $21.97B | $4.19B | 19.07% |
| 2024-06-30 | $21.39B | $4.02B | 18.78% |
| 2024-03-31 | $20.96B | $3.92B | 18.69% |
| 2023-12-31 | $20.50B | $3.67B | 17.92% |
| 2023-09-30 | $19.89B | $3.21B | 16.13% |
| 2023-06-30 | $19.46B | $3.16B | 16.22% |
| 2023-03-31 | $18.95B | $2.98B | 15.70% |
| 2022-12-31 | $18.45B | $2.68B | 14.54% |
| 2022-09-30 | $17.95B | $2.68B | 14.93% |
| 2022-06-30 | $17.63B | $2.36B | 13.38% |
| 2022-03-31 | $17.43B | $2.30B | 13.20% |
| 2021-12-31 | $17.11B | $2.28B | 13.33% |
| 2021-09-30 | $16.67B | $2.20B | 13.17% |
| 2021-06-30 | $16.25B | $2.48B | 15.27% |
| 2021-03-31 | $14.72B | $1.73B | 11.76% |
| 2020-12-31 | $14.35B | $1.95B | 13.62% |
| 2020-09-30 | $14.22B | $2.22B | 15.60% |
| 2020-06-30 | $14.07B | $2.02B | 14.36% |
| 2020-03-31 | $14.96B | $2.67B | 17.87% |
| 2019-12-31 | $14.88B | $2.56B | 17.21% |
| 2019-09-30 | $14.55B | $2.28B | 15.69% |
| 2019-06-30 | $14.20B | $2.24B | 15.74% |
| 2019-03-31 | $13.88B | $2.29B | 16.53% |
| 2018-12-31 | $13.60B | $2.36B | 17.32% |
| 2018-09-30 | $13.28B | $2.35B | 17.69% |
| 2018-06-30 | $13.04B | $2.29B | 17.52% |
| 2018-03-31 | $12.73B | $2.11B | 16.54% |
| 2017-12-31 | $12.44B | $2.06B | 16.58% |
| 2017-09-30 | $12.13B | $2.00B | 16.50% |
| 2017-06-30 | $11.96B | $1.95B | 16.31% |
| 2017-03-31 | $11.79B | $1.94B | 16.45% |
| 2016-12-31 | $11.33B | $1.92B | 16.96% |
| 2016-09-30 | $10.88B | $1.95B | 17.87% |
| 2016-06-30 | $10.47B | $1.87B | 17.87% |
| 2016-03-31 | $10.06B | $1.84B | 18.28% |
| 2015-12-31 | $9.95B | $1.74B | 17.44% |
| 2015-09-30 | $9.85B | $1.58B | 16.08% |
| 2015-06-30 | $9.82B | $1.66B | 16.95% |
| 2015-03-31 | $9.75B | $1.43B | 14.67% |
| 2014-12-31 | $9.68B | $1.16B | 11.99% |
| 2014-09-30 | $9.53B | $1.13B | 11.86% |
| 2014-06-30 | $9.29B | $0.84B | 9.07% |
| 2014-03-31 | $9.14B | $0.94B | 10.33% |
| 2013-12-31 | $9.02B | $1.21B | 13.44% |
| 2013-09-30 | $8.89B | $1.14B | 12.81% |
| 2013-06-30 | $8.79B | $1.45B | 16.45% |
| 2013-03-31 | $8.69B | $1.61B | 18.56% |
| 2012-12-31 | $8.66B | $1.71B | 19.70% |
| 2012-09-30 | $8.53B | $1.78B | 20.86% |
| 2012-06-30 | $8.51B | $1.77B | 20.76% |
| 2012-03-31 | $8.45B | $1.74B | 20.62% |
| 2011-12-31 | $8.31B | $1.69B | 20.30% |
| 2011-09-30 | $8.09B | $1.63B | 20.18% |
| 2011-06-30 | $7.82B | $1.66B | 21.26% |
| 2011-03-31 | $7.54B | $1.70B | 22.49% |
| 2010-12-31 | $7.32B | $1.73B | 23.63% |
| 2010-09-30 | $7.16B | $1.87B | 26.18% |
| 2010-06-30 | $7.04B | $1.73B | 24.50% |
| 2010-03-31 | $6.92B | $1.68B | 24.32% |
| 2009-12-31 | $6.72B | $1.62B | 24.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $149.082B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.767B | 27.38 |
| Boston Scientific (BSX) | United States | $151.377B | 43.52 |
| EssilorLuxottica (ESLOY) | France | $125.055B | 0.00 |
| Medtronic (MDT) | Ireland | $117.214B | 17.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.950B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.139B | 28.03 |
| GE HealthCare Technologies (GEHC) | United States | $40.136B | 20.82 |
| ResMed (RMD) | United States | $37.119B | 30.50 |
| Terumo (TRUMY) | Japan | $28.886B | 41.07 |
| Koninklijke Philips (PHG) | Netherlands | $25.642B | 19.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.107B | 14.07 |
| Insulet (PODD) | United States | $19.438B | 77.40 |
| Baxter (BAX) | United States | $16.737B | 10.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.084B | 40.57 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.966B | 33.87 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.433B | 14.95 |
| ICU Medical (ICUI) | United States | $4.121B | 39.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.893B | 19.36 |
| Envista Holdings (NVST) | United States | $3.678B | 27.40 |
| Haemonetics (HAE) | United States | $3.430B | 16.74 |
| Perrigo (PRGO) | Ireland | $3.366B | 9.91 |
| GN Store Nord (GNNDY) | Denmark | $3.027B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.927B | 18.84 |
| Neogen (NEOG) | United States | $2.495B | 28.75 |
| LeMaitre Vascular (LMAT) | United States | $2.247B | 54.60 |
| AtriCure (ATRC) | United States | $2.067B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.464B | 25.63 |
| InMode (INMD) | Israel | $1.462B | 8.79 |
| AdaptHealth (AHCO) | United States | $1.430B | 10.22 |
| BioLife Solutions (BLFS) | United States | $1.313B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.270B | 0.00 |
| Owens & Minor (OMI) | United States | $1.150B | 8.99 |
| Evolus (EOLS) | United States | $0.922B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.887B | 15.64 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.830B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.649B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 24.73 |
| Surmodics (SRDX) | United States | $0.511B | 0.00 |
| Omeros (OMER) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.429B | 0.00 |
| Valneva SE (VALN) | France | $0.412B | 0.00 |
| ZimVie (ZIMV) | United States | $0.401B | 33.77 |
| Quanterix (QTRX) | United States | $0.370B | 0.00 |
| Cerus (CERS) | United States | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.322B | 30.67 |
| Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
| Biote (BTMD) | United States | $0.309B | 6.76 |
| OraSure Technologies (OSUR) | United States | $0.291B | 19.50 |
| Canopy Growth (CGC) | Canada | $0.265B | 0.00 |
| Zynex (ZYXI) | United States | $0.263B | 55.13 |
| High Tide (HITI) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.52 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 104.70 |
| MacroGenics (MGNX) | United States | $0.190B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.27 |
| Quipt Home Medical (QIPT) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| INLIF (INLF) | $0.071B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.35 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |